Bone marrow from six patients with acute myeloid leukemia plasmid and a cosmid probe specific for the breakpoint (AML) and t(8;21) (q22;q22) or a variant t(8;13;21) was studied regions of chromosome 8 and 21, ie a P1.164 probe contain- 
were examined. The diagnosis de novo AML was made while there was no clinical suspicion of a previous MDS phase nor features of tri-lineage dysplasia. The morphological diagnosis Introduction was made according to the French-American-British (FAB) criteria. 3 Cytogenetic analysis was performed using standard The t(8;21) (q22;q22) is a balanced reciprocal translocation banding techniques. Reverse transcriptase-polymerase chain found in approximately 6% of all adult cases with acute reaction (RT-PCR) was performed as described previously myeloid leukemia (AML). 1 Most of these cases are classified using an antisense primer based on the sequence of the ETO as French-American-British (FAB) subtype M2. 2, 3 The gene and a sense primer based on the sequence of the AML1 cytology of the bone marrow cells is very characteristic: blasts gene. 7 Hematological and cytogenetical characteristics of all often contain Auer rods. The more mature granulocytic patients are summarized in Table 1 . We considered patient elements often show salmon to orange coloration of the cytoNo. 5 as having AML-M2 although at the time of bone marrow plasm and lack of granulation. Bone marrow eosinophilia can sampling the percentages of blasts were less than 30%. 12, 13 be found and the number of erythroblasts is low as is the numHowever after 1 week a second marrow aspirate showed that ber of megakaryocytes. 2, 4 the percentage of blasts had increased to 35.8%. In one The breakpoint on chromosome 21 has been shown patient (No. 6) chromosome 13 was also involved in the transbetween exons 5 and 6 of the AML1 gene and on chromolocation. The AML1/ETO fusion gene however was still some 8 the ETO gene is involved. 5, 6 As a result of the translolocated on the 8 chromosome. cation an identical AML1/ETO fusion transcript can be Bone marrow slides were made according to standard diagdetected irrespective of the exact breakpoint location within nostic procedures and stained with MGG. Slides were the AML1 intron. 7 This chimeric gene is thought to generate wrapped in foil and stored at −20°C until time of hybridiza novel protein that probably contributes to the development ation. In addition, bone marrow slides of control patients withof the leukemia. Metaphase cytogenetics was used which limits these studies to cells able to divide. It was suggested that the translocation Fluorescent in situ hybridization and probes was found in myeloblasts only and not in erythroblasts or Tlymphocytes. To investigate cell-lineage involvement of the One hundred and seventy-five nanograms of a biotin-labeled leukemia the combination of cytology and interphase cytoplasmid P1.164 specific for the q22 region of chromosome 8 genetics using centromeric specific DNA probes has proved to and 175 ng of a digoxigenin-labeled cosmid CO.664 specific be a powerful technique. May-Grü nwald-Giemsa combined for the q22 region of chromosome 21 were mixed with 10 ng with fluorescence in situ hybridization (MGG/FISH) has been of Cot-1 DNA (Gibco BRL, Gaithersburg, MD, USA). 11 This used to detect numerical cytogenetic changes in different cell mixture was then denaturated at 70°C for 4 min and allowed types. 10 We have adapted the MGG/FISH technique using a to preanneal at 37°C for 15 min to suppress repetitive DNA sequences. The MGG-stained bone marrow slides were thawed slowly and denaturated in 70% formamide 2 × SSC for 2.5 min after which a mixture of the probes was applied.
Correspondence: K van Lom, Dept of Hematology, University HospiAfter overnight incubation in a moist chamber at 37°C, a post- ine (Vector Laboratories, Burlingame, CA, USA) and amplified distance between a green and red spot was less than one spot wide. Images of the fluorescent spots were captured on the with anti-avidine (Vector Laboratories) followed by avidine-FITC. The digoxigenin-labeled probe was detected by sheepProbemaster Unit PSI (Chester). anti-digoxigenin-Rhodamine (Boehringer Mannheim) after which a second layer of Texas red-labeled donkey anti-sheep antibody (Jackson Immunoresearch Laboratories), was Results applied. Cells were counterstained with DAPI (Serva) which was solved in the antifade solution Vecta shield (Vector RT-PCR was performed to detect the presence of the fusion transcript: the 298 bp was generated by amplification in all Laboratories). The slides were covered with glass coverslips. six cases. MGG-stained bone marrow cells of four patients without cytogenetic aberrations and without major cytological abnorEvaluation of the FISH spots and photography malities revealed two green and two red spots in 97.2% ± 1.5 of the cells (mean ± standard deviation). The fluorescent spots Using simultaneous analysis of the cytology of cells on the video screen and the FISH spots in the fluorescence microwere small but bright and clearly visible against a very low fluorescent background. Per control patient 500 cells were scope, we were able to relate the cytogenetic abnormality to specific cell types. studied, thus including erythroblasts, myeloid cells and lymphoid cells. In 3.0% of the cells (s.d. ± 1.1) a green spot Only cells with two red and two green fluorescent spots were evaluated. Cells were considered positive for the translowas distinguished next to a red spot. In one control patient cytology was combined with FISH (Table 2 ). In low percentcation when a yellow fusion spot was visible or when the myelocytes, metamyelocytes, stab cells and segmented neutrophils either a fusion spot or a close pairing of a green and a red spot were seen (Figure 1 ). In one patient (No. 4) the eosinophilic lineage was also studied. All analyzable eosinophils showed the t(8;21). Normal values of pairs of red and green spots were observed in erythroblasts and lymphocytes. Megakaryocytes were not studied.
Discussion
AML with t(8;21) represents a subtype of the acute leukemias with characteristic cytology, immunological phenotype and distinct prognosis. Few studies have dealt with the investigation of cell lineage involvement in AML with t(8;21). Knuutila et al 9 used the morphology-antibody-chromosomes (MAC) technique in one patient and found t(8;21) only in CD13-positive metaphase cells (granulocytic lineage). The glycophorin A-positive (erythroid) and CD3 (T-lymphocytes)-positive metaphase cells did not show the translocation. Berger et al 4 studied 10 patients with AML and t(8;21) by comparing the number of blasts and erythroblasts to the number of normal and abnormal metaphases and suggested that only myeloblasts were cytogenetically abnormal.
The strength of the investigations reported here is the use of breakpoint-specific probes for the analysis of the primary cytogenetic event. The combination of MGG and FISH permits a direct comparison of cytology and karyotype. The often dysplastic granulocytic line appears to be an integral part of the abnormal clone. In one patient (No. 4) the percentage of eosinophils was slightly elevated. We found these cells to belong to the malignant clone as well. One of the characteristics of this type of AML is the ability of eosinophilic maturation when blasts are stimulated in vitro with IL-5.
14 The percentage of erythroblasts and lymphocytes with pairing of a green and red spot was within the normal range. Lack of sensitivity of the technique used (3% false positive ± 1.1, cut-off 5.2%) is inherent to the technique and best explained by the fact that the volume of the cell is projected and analyzed as a flat surface. Therefore, we cannot exclude the possibility that single cells in the erythroid and lymphoid lineage belong to the cytogenetically abnormal clone.
In addition to the experiments described in this paper, we also performed cytology combined with FISH using the loss of a sex chromosome as a marker. 15 The loss of a sex chromosome is often associated with t(8;21), suggesting that this is secondary to the structural rearrangement. 4 Only blasts and more mature myeloid cells were found to be cytogenetically abnormal.
Many patients in long-term remission still express the AML1/ETO transcript. This suggests the presence of a preleukemic population. Recent evidence suggests that this popu- The fact that we did not find involvement of the t(8;21) in (q22) (green spots) and No. 21 (q22) (red spots).
erythroblasts and lymphocytes, would therefore suggest that during leukemia the cells with the cytogenetic abnormality are programmed to proliferate mainly into the granulocytic linages of erythroblasts, neutrophils and lymphocytes, pairing of a green and red spot was observed. The number of blasts eage.
In three of six patients the karyogram showed normal metainvestigated was low (six), no fusion spots were seen in eosinophils.
phases next to metaphases with t(8;21). However, in MGG/FISH almost all blasts express t(8;21). These differences Table 2 also contains the results of parallel analysis of cytology and cytogenetics of the patients' bone marrow. The are most likely explained by the fact that bone marrow cultures for cytogenetic analysis include nonmalignant cells that percentages of cells positive for the t(8;21) are expressed per cell type. In all blasts and in high percentages of more mature are stimulated in vitro.
In conclusion, erythroid and lymphoid cells are not part of and often dysplastic myeloid cells including promyelocytes,
